Clinical Trials Directory

Trials / Completed

CompletedNCT06958354

Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients

Status
Completed
Phase
Study type
Observational
Enrollment
1,529 (actual)
Sponsor
Gulhane Training and Research Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers

Summary

In intensive care units, sepsis, which can be defined as bacteremia and the irregular and uncontrolled inflammatory response to it, is one of the most important causes of mortality. Early recognition of sepsis and appropriate antibiotic use for the causative agent is one of the most important steps in the fight against sepsis. Procalcitonin (PCT) is a calcitonin precursor peptide and has been reported to predict bacteremia early. While the PCT concentration level is negligible in healthy individuals, it has been shown to increase especially in bacterial infections, sepsis, trauma and burns. In our study, our aim is to determine whether there is a relationship between serum PCT concentration levels taken within 24 hours according to the time of the sample taken for blood culture with growth in patients followed up in our Internal Intensive Care Unit.

Conditions

Timeline

Start date
2023-03-15
Primary completion
2025-01-01
Completion
2025-10-19
First posted
2025-05-06
Last updated
2025-12-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06958354. Inclusion in this directory is not an endorsement.